Early Detection & Intervention of Cerebral Palsy in Ireland
NCT ID: NCT05907837
Last Updated: 2023-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2023-07-01
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This project will aim to improve the Early Detection of Cerebral Palsy in Ireland. This will be achieved by implementing an evidence-based approach to follow-up of High risk infants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing Intellectual and Motor Outcomes in High-risk Infants
NCT06857539
Risk Factors , Types and Neuroimaging Findings in Patients With Cerebral Palsy at Assiut University Children's Hospital
NCT06928012
Natural History of Cerebral Palsy Prospective Study
NCT05576948
Early Remote At-risk Diagnosis for Cerebral Palsy in Follow-up Clinics for High-risk Infants
NCT04287166
Experiences of Managing Sleep Disordered Breathing in Children With Cerebral Palsy.
NCT06753370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All infants considered high risk for cerebral palsy and neuro-developmental impairment will be eligible, specifically including:
* All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight
* All encephalopathic infants
* Neurological risk factors (e.g., injury/malformation on neuroimaging, persistently abnormal neurological exam)
Exclusion Criteria
40 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Maternity Hospital, Ireland
OTHER
University Maternity Hospital Limerick
UNKNOWN
Cork University Maternity Hospital
OTHER
Coombe Women and Infants University Hospital
OTHER
The Rotunda Hospital
OTHER
Cerebral Palsy Foundation
UNKNOWN
University College Cork
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian H Walsh
Role: PRINCIPAL_INVESTIGATOR
University College Cork
Breda Hayes
Role: PRINCIPAL_INVESTIGATOR
The Rotunda Hospital
Deirdre Sweetman
Role: PRINCIPAL_INVESTIGATOR
National Maternity Hospital
Roy Philips
Role: PRINCIPAL_INVESTIGATOR
Limerick University Maternity Hospital
John Kelleher
Role: PRINCIPAL_INVESTIGATOR
Coombe Women and Infants University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cork University Maternity Hospital
Cork, , Ireland
Coombe Women and Infants University Hospital
Dublin, , Ireland
National Maternity Hospital
Dublin, , Ireland
The Rotunda Hospital
Dublin, , Ireland
University Maternity Hospital Limerick
Limerick, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Brian Walsh
Role: primary
John Kelleher
Role: primary
Deirdre Sweetman
Role: primary
Breda Hayes
Role: primary
Roy Philips
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EDI-CPI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.